Wexford Capital »

Seres Therapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $29k 20k 1.40

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
International Seaways (INSW)
Nephros (NEPH)
Ishares Msci Aust Etf (EWA)
Ishares Msci Cda Etf (EWC)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Cenovus Energy (CVE)
Stellantis SHS (STLA)
Cool Common Shares (CLCO)
Astrazeneca Sponsored Adr (AZN)
Silverbow Resources (SBOW)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Golar Lng SHS (GLNG)
Enterprise Products Partners (EPD)

View all positions for Wexford Capital

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
Hudson Bay Capital Management
Bank of America Corporation
Millennium Management
Point72 Asset Management
Tang Capital Management
Handelsbanken Fonder AB
Charles Schwab Investment Management
Goldman Sachs Group
Advisor Group Holdings
Hrt Financial
T. Rowe Price Associates
Two Sigma Investments
Lion Point Capital

View all funds holding Seres Therapeutics